Literature DB >> 26770299

The structure and function of NKAIN2-a candidate tumor suppressor.

Shan-Chao Zhao1, Bo-Wei Zhou1, Fei Luo1, Xueying Mao2, Yong-Jie Lu2.   

Abstract

The deletion of chromosomal region 6q was commonly found in several types of human cancers, although the tumor suppressor genes (TSGs) located within this genomic region are not well established. Our recent work detected recurrent chromosomal truncation at the Na(+)/K(+) transporting ATPase interacting 2 (NKAIN2) gene in prostate cancer, which was also found to be truncated in leukemia and lymphoma, suggesting that NKAIN2 is potentially one of the TSGs located in the 6q commonly deleted region in human cancers. NKAIN2 gene consists of eight coding exons that span approximately 1 Mb of genomic DNA on chromosome 6q and there are four main splice variants. The function of this gene is not well investigated and the limited knowledge of this gene pointed to nervous system development. The chromosomal translocations in nervous development disorders usually lead to inactivation of this gene. In human tumors, both chromosomal deletion and translocation may also inactivate this gene and consequently contribute to tumorigenesis. Further genetic and cellular functional studies are required to establish its tumor suppressor role.

Entities:  

Keywords:  Chromosomal deletion; NKAIN2 (TCBA1); genomic rearrangement; tumor suppressor gene

Year:  2015        PMID: 26770299      PMCID: PMC4694199     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  59 in total

1.  Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques.

Authors:  Marilanda Ferreira Bellini; Ana Elizabete Silva; Marileila Varella-Garcia
Journal:  Genet Mol Biol       Date:  2010-06-01       Impact factor: 1.771

2.  Allelic loss in clinically and screening-detected primary hyperparathyroidism.

Authors:  Pamela Correa; Christofer Juhlin; Jonas Rastad; Göran Akerström; Gunnar Westin; Tobias Carling
Journal:  Clin Endocrinol (Oxf)       Date:  2002-01       Impact factor: 3.478

Review 3.  Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune.

Authors:  Karin van den Hurk; Hanneke E C Niessen; Jürgen Veeck; Joost J van den Oord; Maurice A M van Steensel; Axel Zur Hausen; Manon van Engeland; Véronique J L Winnepenninckx
Journal:  Biochim Biophys Acta       Date:  2012-03-31

4.  Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines.

Authors:  Adrie van Bokhoven; Aimee Caires; Michael Di Maria; Aline Passarini Schulte; M Scott Lucia; Steven K Nordeen; Gary J Miller; Marileila Varella-Garcia
Journal:  Prostate       Date:  2003-11-01       Impact factor: 4.104

Review 5.  Genomic Predictors of Outcome in Prostate Cancer.

Authors:  Peter J Boström; Anders S Bjartell; James W F Catto; Scott E Eggener; Hans Lilja; Stacy Loeb; Jack Schalken; Thorsten Schlomm; Matthew R Cooperberg
Journal:  Eur Urol       Date:  2015-04-23       Impact factor: 20.096

6.  TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.

Authors:  Keiichiro Honma; Shinobu Tsuzuki; Masao Nakagawa; Hiroyuki Tagawa; Shigeo Nakamura; Yasuo Morishima; Masao Seto
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

Review 7.  Breakpoint clusters: reason or consequence?

Authors:  Andrey A Bystritskiy; Sergey V Razin
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2004       Impact factor: 1.807

Review 8.  Raf proteins and cancer: B-Raf is identified as a mutational target.

Authors:  Kathryn E Mercer; Catrin A Pritchard
Journal:  Biochim Biophys Acta       Date:  2003-06-05

9.  Rapid high-resolution karyotyping with precise identification of chromosome breakpoints.

Authors:  Xueying Mao; Sharon Y James; Rafael J Yáñez-Muñoz; Tracy Chaplin; Gael Molloy; R Tim D Oliver; Bryan D Young; Yong-Jie Lu
Journal:  Genes Chromosomes Cancer       Date:  2007-07       Impact factor: 5.006

10.  The genomic complexity of primary human prostate cancer.

Authors:  Michael F Berger; Michael S Lawrence; Francesca Demichelis; Yotam Drier; Kristian Cibulskis; Andrey Y Sivachenko; Andrea Sboner; Raquel Esgueva; Dorothee Pflueger; Carrie Sougnez; Robert Onofrio; Scott L Carter; Kyung Park; Lukas Habegger; Lauren Ambrogio; Timothy Fennell; Melissa Parkin; Gordon Saksena; Douglas Voet; Alex H Ramos; Trevor J Pugh; Jane Wilkinson; Sheila Fisher; Wendy Winckler; Scott Mahan; Kristin Ardlie; Jennifer Baldwin; Jonathan W Simons; Naoki Kitabayashi; Theresa Y MacDonald; Philip W Kantoff; Lynda Chin; Stacey B Gabriel; Mark B Gerstein; Todd R Golub; Matthew Meyerson; Ashutosh Tewari; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

View more
  6 in total

Review 1.  EWSR1/FUS-NFATc2 rearranged round cell sarcoma: clinicopathological series of 4 cases and literature review.

Authors:  Julio A Diaz-Perez; G Petur Nielsen; Cristina Antonescu; Martin S Taylor; Santiago A Lozano-Calderon; Andrew E Rosenberg
Journal:  Hum Pathol       Date:  2019-05-09       Impact factor: 3.466

2.  Transcriptome profiling reveals PDZ binding kinase as a novel biomarker in peritumoral brain zone of glioblastoma.

Authors:  Banavathy S Kruthika; Ruchi Jain; A Arivazhagan; R D Bharath; T C Yasha; Paturu Kondaiah; Vani Santosh
Journal:  J Neurooncol       Date:  2018-11-20       Impact factor: 4.130

3.  The cerebrospinal fluid proteome of preterm infants predicts neurodevelopmental outcome.

Authors:  Kristin Leifsdottir; Kerstin Jost; Veronica Siljehav; Eric P Thelin; Philipp Lassarén; Peter Nilsson; Ásgeir Haraldsson; Staffan Eksborg; Eric Herlenius
Journal:  Front Pediatr       Date:  2022-07-19       Impact factor: 3.569

4.  Novel mutational landscapes and expression signatures of lung squamous cell carcinoma.

Authors:  Donghai Xiong; Jing Pan; Yuxin Yin; Hui Jiang; Eva Szabo; Ronald A Lubet; Yian Wang; Ming You
Journal:  Oncotarget       Date:  2017-12-27

5.  The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs.

Authors:  Heung Woo Park; Sang Heon Kim; Yoon Seok Chang; Sang Hoon Kim; Young Koo Jee; Ai Young Lee; In Jin Jang; Hae Sim Park; Kyung Up Min
Journal:  Allergy Asthma Immunol Res       Date:  2018-09       Impact factor: 5.764

6.  Genome-wide association study identifies SIAH3 locus influencing the rate of ventricular enlargement in non-demented elders.

Authors:  Xian Li; Shu-Guang Chu; Xue-Ning Shen; Xiao-He Hou; Wei Xu; Ya-Nan Ou; Qiang Dong; Lan Tan; Jin-Tai Yu
Journal:  Aging (Albany NY)       Date:  2019-11-11       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.